Delayed
NSE India S.E.
04:26:18 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
339.2
INR
|
+1.22%
|
|
-0.28%
|
+2.20%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
11,491
|
7,861
|
1,818
|
8,799
|
16,040
|
17,634
|
Enterprise Value (EV)
1 |
11,601
|
9,304
|
1,918
|
8,710
|
14,952
|
15,427
|
P/E ratio
|
18.8
x
|
15.2
x
|
6.32
x
|
6.5
x
|
6.96
x
|
7.57
x
|
Yield
|
0.63%
|
0.92%
|
3.99%
|
1.38%
|
3.02%
|
2.74%
|
Capitalization / Revenue
|
0.87
x
|
0.62
x
|
0.18
x
|
0.61
x
|
0.75
x
|
0.78
x
|
EV / Revenue
|
0.87
x
|
0.73
x
|
0.19
x
|
0.6
x
|
0.7
x
|
0.69
x
|
EV / EBITDA
|
10.6
x
|
8.12
x
|
3.32
x
|
4.48
x
|
4.97
x
|
4.76
x
|
EV / FCF
|
-539
x
|
-7.59
x
|
1.37
x
|
328
x
|
17.2
x
|
13
x
|
FCF Yield
|
-0.19%
|
-13.2%
|
73%
|
0.3%
|
5.81%
|
7.68%
|
Price to Book
|
3.09
x
|
1.9
x
|
0.42
x
|
1.57
x
|
2.09
x
|
1.85
x
|
Nbr of stocks (in thousands)
|
60,494
|
60,494
|
60,494
|
60,494
|
60,494
|
60,494
|
Reference price
2 |
190.0
|
130.0
|
30.05
|
145.4
|
265.2
|
291.5
|
Announcement Date
|
5/25/18
|
8/20/19
|
8/10/20
|
8/6/21
|
8/5/22
|
5/30/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
13,273
|
12,693
|
10,028
|
14,470
|
21,324
|
22,487
|
EBITDA
1 |
1,097
|
1,146
|
578.1
|
1,944
|
3,011
|
3,243
|
EBIT
1 |
1,044
|
1,086
|
510.8
|
1,876
|
2,935
|
3,155
|
Operating Margin
|
7.87%
|
8.56%
|
5.09%
|
12.97%
|
13.76%
|
14.03%
|
Earnings before Tax (EBT)
1 |
901.5
|
715.4
|
321.4
|
1,795
|
2,863
|
2,946
|
Net income
1 |
609.7
|
518.8
|
287.8
|
1,354
|
2,303
|
2,330
|
Net margin
|
4.59%
|
4.09%
|
2.87%
|
9.35%
|
10.8%
|
10.36%
|
EPS
2 |
10.08
|
8.577
|
4.757
|
22.37
|
38.08
|
38.51
|
Free Cash Flow
1 |
-21.54
|
-1,225
|
1,400
|
26.53
|
869.1
|
1,185
|
FCF margin
|
-0.16%
|
-9.65%
|
13.96%
|
0.18%
|
4.08%
|
5.27%
|
FCF Conversion (EBITDA)
|
-
|
-
|
242.15%
|
1.36%
|
28.87%
|
36.55%
|
FCF Conversion (Net income)
|
-
|
-
|
486.44%
|
1.96%
|
37.73%
|
50.88%
|
Dividend per Share
2 |
1.200
|
1.200
|
1.200
|
2.000
|
8.000
|
8.000
|
Announcement Date
|
5/25/18
|
8/20/19
|
8/10/20
|
8/6/21
|
8/5/22
|
5/30/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
110
|
1,443
|
99.9
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
88.4
|
1,088
|
2,207
|
Leverage (Debt/EBITDA)
|
0.1003
x
|
1.259
x
|
0.1728
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-21.5
|
-1,225
|
1,400
|
26.5
|
869
|
1,185
|
ROE (net income / shareholders' equity)
|
17.8%
|
13.2%
|
6.8%
|
27.2%
|
34.7%
|
27.1%
|
ROA (Net income/ Total Assets)
|
7.94%
|
7.17%
|
3.81%
|
13.4%
|
16.3%
|
15.9%
|
Assets
1 |
7,682
|
7,241
|
7,554
|
10,097
|
14,101
|
14,696
|
Book Value Per Share
2 |
61.40
|
68.40
|
71.60
|
92.70
|
127.0
|
157.0
|
Cash Flow per Share
2 |
4.420
|
1.200
|
5.030
|
11.60
|
10.20
|
16.00
|
Capex
1 |
185
|
233
|
201
|
250
|
301
|
353
|
Capex / Sales
|
1.39%
|
1.83%
|
2.01%
|
1.73%
|
1.41%
|
1.57%
|
Announcement Date
|
5/25/18
|
8/20/19
|
8/10/20
|
8/6/21
|
8/5/22
|
5/30/23
|
|
1st Jan change
|
Capi.
|
---|
| +1.20% | 67.05B | | +44.29% | 40.4B | | +15.99% | 38.64B | | +4.67% | 32.41B | | +6.59% | 19.17B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.82B | | -14.74% | 13.81B |
Other Commodity Chemicals
|